Insurance Patterns of Medicaid Beneficiaries With Sickle Cell Disease in California and Georgia, 2014 to 2016

Insurance Patterns of Medicaid Beneficiaries With Sickle Cell Disease in California and Georgia, 2014 to 2016

Sickle cell disease (SCD) is an inherited hemoglobinopathy
characterized by sickle hemoglobin polymerization and
erythrocyte sickling.1,2

Persons with SCD experience lifelong complications stemming
from chronic hemolytic anemia and repeated episodes of acute
pain that lead to reduced quality of life, increased disability, and
early mortality.1,2

Continued care is essential for improving outcomes in persons
living with SCD.3

While a substantial proportion of those living with SCD are
insured through Medicaid, the consistency of coverage has not
been examined.

Paulukonis, S., Zhou, M., Snyder, A., Cong, Z., Agodoa, I., El-Haj, N., Hulihan, M. (2020, September). Insurance Patterns of Medicaid Beneficiaries With Sickle Cell Disease in California and Georgia, 2014 to 2016 [Conference Presentation]. Annual Sickle Cell Disease Research and Education Symposium, Florida, United States.